Uzbekistan has received 1 million doses of the Sino-Uzbek vaccine ZF-UZ-VAC2001.
It is a novel recombinant coronavirus vaccine developed by scientists of the Institute of Microbiology at the Chinese Academy of Sciences and manufactured by the pharmaceutical company Anhui Zhifei Longcom Biopharmaceutical Co. Ltd.
Its clinical trials were carried out in collaboration with Uzbek scientists.
At present, the population over 18 years of age is vaccinated with ZF-UZ-VAC2001 in Tashkent.
